Company / Working Capital per Share
Spero Therapeutics, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.07
FY2025
5-year range
$1.07 / $4.76
FY2021-FY2025
Trend
-2.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 5 consecutive years, from $6.50 in FY2020 to $1.07 in FY2025.
Based on SEC 10-K filings.
1.07 in FY2025 with a 5-year CAGR of -30.3%.
Declined from $1.79 to $1.07 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -27.8%
- 5-Year CAGR
- -30.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- Spero Therapeutics, Inc.'s working capital per share has declined for 5 consecutive years.
- In FY2025, working capital per share decreased 2.6% year-over-year.
- Peak working capital per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.07 | -2.6% |
| FY2024 | $1.10 | -38.8% |
| FY2023 | $1.79 | -36.8% |
| FY2022 | $2.84 | -40.4% |
| FY2021 | $4.76 | -26.8% |
| FY2020 | $6.50 | +62.8% |
| FY2019 | $4.00 | -48.7% |
| FY2018 | $7.79 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026